Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023
Metabolism: Clinical and Experimental · Published 2026-07-27 · DOI 10.1016/j.metabol.2026.156716
Authors (21)
Jayanth Jayabaskaran, Srinithy Nagarajan, Haryo Raden Himan, Jordan Kok, Ernest En-Rae Tan, Bryan Chong, Gwyneth Kong, Yiming Chen, H.S. Jocelyn Chew, Muhammad Shahzeb Khan, Jiong-Wei Wang, Mamas A. Mamas, Xiao-Dong Zhou, Ming-Hua Zheng, Christopher D. Byrne, Giovanni Targher, Derek Hausenloy, Gregory Lip, Mark Y. Chan, Stephen J. Nicholls, Nicholas W.S. Chew
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Jayabaskaran, J., Nagarajan, S., Himan, H., et al. (2026). Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023. Metabolism: Clinical and Experimental. https://doi.org/10.1016/j.metabol.2026.156716
Related articles
- Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3 · Metabolism: Clinical and Experimental · 2026 · Cites or is cited by this article · Same journal
- Cardiovascular health factors and altered proteomic landscapes in the progression of cardiovascular-kidney-metabolic syndrome: Evidence from multi-cohorts in China, the UK, and the US · Metabolism: Clinical and Experimental · 2026 · Cites or is cited by this article · Same journal
- Global Prevalence, Incidence, and Outcomes of Coexisting MASLD and Chronic Kidney Disease: A Meta‐Analysis · Liver International · 2026 · Cites or is cited by this article
- GLP-1 Receptor Agonists and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction · American Journal of Cardiology · 2026 · Cites or is cited by this article
- Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 · Journal of the American College of Cardiology · 2025 · Cites or is cited by this article
- Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 · The Lancet · 2025 · Cites or is cited by this article
- Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 · The Lancet · 2025 · Cites or is cited by this article
- Long-term prognosis of coexistent metabolic dysfunction–associated steatotic liver disease and chronic kidney disease following acute myocardial infarction · Clinical Research in Cardiology · 2026 · Cites or is cited by this article
- Dynamic regulation of circulating endotrophin by changes in fat mass in humans · Metabolism: Clinical and Experimental · 2026 · Same journal
- Cytochrome P450 2E1 deficiency alters hepatic mitochondria and impairs liver organoid formation · Metabolism: Clinical and Experimental · 2026 · Same journal